vs

Side-by-side financial comparison of Dominari Holdings Inc. (DOMH) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.

MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $30.1M, roughly 1.7× Dominari Holdings Inc.). MARAVAI LIFESCIENCES HOLDINGS, INC. runs the higher net margin — -71.6% vs -438.1%, a 366.6% gap on every dollar of revenue. On growth, Dominari Holdings Inc. posted the faster year-over-year revenue change (220.4% vs -11.8%). Over the past eight quarters, Dominari Holdings Inc.'s revenue compounded faster (369.1% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

DOMH vs MRVI — Head-to-Head

Bigger by revenue
MRVI
MRVI
1.7× larger
MRVI
$49.9M
$30.1M
DOMH
Growing faster (revenue YoY)
DOMH
DOMH
+232.2% gap
DOMH
220.4%
-11.8%
MRVI
Higher net margin
MRVI
MRVI
366.6% more per $
MRVI
-71.6%
-438.1%
DOMH
Faster 2-yr revenue CAGR
DOMH
DOMH
Annualised
DOMH
369.1%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DOMH
DOMH
MRVI
MRVI
Revenue
$30.1M
$49.9M
Net Profit
$-131.8M
$-35.7M
Gross Margin
25.8%
Operating Margin
-8.9%
-117.9%
Net Margin
-438.1%
-71.6%
Revenue YoY
220.4%
-11.8%
Net Profit YoY
-12426.2%
-37.7%
EPS (diluted)
$-6.94
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOMH
DOMH
MRVI
MRVI
Q4 25
$30.1M
$49.9M
Q3 25
$50.8M
$41.6M
Q2 25
$34.1M
$47.4M
Q1 25
$8.1M
$46.9M
Q4 24
$9.4M
$56.6M
Q3 24
$4.0M
$69.0M
Q2 24
$6.2M
$69.4M
Q1 24
$1.4M
$64.2M
Net Profit
DOMH
DOMH
MRVI
MRVI
Q4 25
$-131.8M
$-35.7M
Q3 25
$125.2M
$-25.6M
Q2 25
$16.6M
$-39.6M
Q1 25
$-32.5M
$-29.9M
Q4 24
$1.1M
$-25.9M
Q3 24
$-4.2M
$-97.1M
Q2 24
$-6.1M
$-9.8M
Q1 24
$-5.4M
$-12.1M
Gross Margin
DOMH
DOMH
MRVI
MRVI
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
DOMH
DOMH
MRVI
MRVI
Q4 25
-8.9%
-117.9%
Q3 25
-3.1%
-98.6%
Q2 25
-57.0%
-139.8%
Q1 25
-394.6%
-104.9%
Q4 24
0.4%
-66.7%
Q3 24
-79.1%
-239.9%
Q2 24
-44.3%
-19.4%
Q1 24
-205.2%
-29.4%
Net Margin
DOMH
DOMH
MRVI
MRVI
Q4 25
-438.1%
-71.6%
Q3 25
246.4%
-61.4%
Q2 25
48.7%
-83.5%
Q1 25
-400.5%
-63.9%
Q4 24
11.4%
-45.8%
Q3 24
-104.2%
-140.6%
Q2 24
-99.1%
-14.1%
Q1 24
-398.0%
-18.8%
EPS (diluted)
DOMH
DOMH
MRVI
MRVI
Q4 25
$-6.94
$-0.24
Q3 25
$7.27
$-0.18
Q2 25
$1.12
$-0.27
Q1 25
$-3.02
$-0.21
Q4 24
$0.21
$-0.21
Q3 24
$-0.67
$-0.68
Q2 24
$-1.01
$-0.07
Q1 24
$-0.91
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOMH
DOMH
MRVI
MRVI
Cash + ST InvestmentsLiquidity on hand
$80.5M
$216.9M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$69.4M
$212.4M
Total Assets
$112.9M
$770.6M
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOMH
DOMH
MRVI
MRVI
Q4 25
$80.5M
$216.9M
Q3 25
$176.2M
$243.6M
Q2 25
$28.2M
$269.9M
Q1 25
$18.9M
$285.1M
Q4 24
$8.2M
$322.4M
Q3 24
$7.2M
$578.2M
Q2 24
$12.1M
$573.2M
Q1 24
$7.1M
$561.7M
Total Debt
DOMH
DOMH
MRVI
MRVI
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
DOMH
DOMH
MRVI
MRVI
Q4 25
$69.4M
$212.4M
Q3 25
$210.2M
$245.4M
Q2 25
$88.6M
$265.9M
Q1 25
$42.4M
$300.6M
Q4 24
$39.9M
$325.3M
Q3 24
$38.3M
$344.9M
Q2 24
$42.4M
$434.7M
Q1 24
$47.7M
$410.7M
Total Assets
DOMH
DOMH
MRVI
MRVI
Q4 25
$112.9M
$770.6M
Q3 25
$223.4M
$849.2M
Q2 25
$109.3M
$897.0M
Q1 25
$52.3M
$959.8M
Q4 24
$47.1M
$1.0B
Q3 24
$43.4M
$1.3B
Q2 24
$49.1M
$1.4B
Q1 24
$52.2M
$1.4B
Debt / Equity
DOMH
DOMH
MRVI
MRVI
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOMH
DOMH
MRVI
MRVI
Operating Cash FlowLast quarter
$22.7M
$-22.8M
Free Cash FlowOCF − Capex
$-24.9M
FCF MarginFCF / Revenue
-49.9%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOMH
DOMH
MRVI
MRVI
Q4 25
$22.7M
$-22.8M
Q3 25
$-4.9M
$-15.2M
Q2 25
$-353.0K
$-10.3M
Q1 25
$1.2M
$-9.4M
Q4 24
$-16.7M
$-14.6M
Q3 24
$-4.7M
$13.1M
Q2 24
$1.4M
$17.4M
Q1 24
$-8.6M
$-8.5M
Free Cash Flow
DOMH
DOMH
MRVI
MRVI
Q4 25
$-24.9M
Q3 25
$-18.1M
Q2 25
$-13.1M
Q1 25
$-14.6M
Q4 24
$-20.5M
Q3 24
$4.5M
Q2 24
$7.9M
Q1 24
$-14.1M
FCF Margin
DOMH
DOMH
MRVI
MRVI
Q4 25
-49.9%
Q3 25
-43.4%
Q2 25
-27.7%
Q1 25
-31.2%
Q4 24
-36.2%
Q3 24
6.6%
Q2 24
11.4%
Q1 24
-22.0%
Capex Intensity
DOMH
DOMH
MRVI
MRVI
Q4 25
4.2%
Q3 25
7.0%
Q2 25
6.1%
Q1 25
11.2%
Q4 24
10.3%
Q3 24
12.4%
Q2 24
13.8%
Q1 24
8.8%
Cash Conversion
DOMH
DOMH
MRVI
MRVI
Q4 25
Q3 25
-0.04×
Q2 25
-0.02×
Q1 25
Q4 24
-15.65×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOMH
DOMH

Chief Operating Decision Maker$30.1M100%
Commissions$458.0K2%

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

Related Comparisons